Type 2 diabetes mellitus: magnitude of the problem and failure to achieve glycemic control (Q36786987)

16 August 2017

1 reference

title

Type 2 diabetes mellitus: magnitude of the problem and failure to achieve glycemic control (English)

1 reference

16 August 2017

1 reference

1

Bernard Zinman

1 reference

16 August 2017

publication date

1 December 2006

1 reference

Endocrinology and Metabolism Clinics of North America

16 August 2017

published in

1 reference

16 August 2017

volume

35 Suppl 1

1 reference

16 August 2017

page(s)

3-5; discussion 17-19

1 reference

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2807%2970003-8

7 January 2021

Economic costs of diabetes in the US in 2002.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2807%2970003-8

7 January 2021

American Diabetes Association diabetes diagnostic criteria, advancing age, and cardiovascular disease risk profiles: results from the Third National Health and Nutrition Examination Survey.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2807%2970003-8

7 January 2021

Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2807%2970003-8

7 January 2021

Weight gain as a risk factor for clinical diabetes mellitus in women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2807%2970003-8

7 January 2021

The contribution of expanding portion sizes to the US obesity epidemic

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2807%2970003-8

7 January 2021

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2807%2970003-8

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2807%2970003-8

7 January 2021

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2807%2970003-8

7 January 2021

Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2807%2970003-8

7 January 2021

Glycemic control of older adults with type 2 diabetes: findings from the Third National Health and Nutrition Examination Survey, 1988-1994.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2807%2970003-8

7 January 2021

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2807%2970003-8

7 January 2021

A diabetes outcome progression trial (ADOPT): an international multicenter study of the comparative efficacy of rosiglitazone, glyburide, and metformin in recently diagnosed type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2807%2970003-8

7 January 2021

10.1016/S0889-8529(07)70003-8

Identifiers

DOI

1 reference

16 August 2017

1 reference